---
title: "PW MEDTECH's subsidiary Sichuan Ruijian Medical earned 151 million RMB last year, an increase of 18%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275770378.md"
description: "PW MEDTECH announced that its subsidiary Sichuan Ruijian Medical (874652.NEEQ) achieved a revenue of RMB 615 million for the fiscal year 2025, an increase of 27.2% year-on-year. The net profit attributable to shareholders was RMB 151 million, a growth of 18%"
datetime: "2026-02-12T14:19:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275770378.md)
  - [en](https://longbridge.com/en/news/275770378.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275770378.md)
---

# PW MEDTECH's subsidiary Sichuan Ruijian Medical earned 151 million RMB last year, an increase of 18%

PW MEDTECH (01358.HK) announced that its subsidiary Sichuan Ruijian Medical (874652.NEEQ) achieved a revenue of 615 million RMB for the fiscal year 2025, an increase of 27.2% year-on-year. The net profit attributable to shareholders was 151 million RMB, a growth of 18%

### Related Stocks

- [01358.HK](https://longbridge.com/en/quote/01358.HK.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [588250.CN](https://longbridge.com/en/quote/588250.CN.md)
- [159883.CN](https://longbridge.com/en/quote/159883.CN.md)
- [159859.CN](https://longbridge.com/en/quote/159859.CN.md)
- [159898.CN](https://longbridge.com/en/quote/159898.CN.md)
- [560600.CN](https://longbridge.com/en/quote/560600.CN.md)
- [516500.CN](https://longbridge.com/en/quote/516500.CN.md)
- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [516820.CN](https://longbridge.com/en/quote/516820.CN.md)
- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)
- [588860.CN](https://longbridge.com/en/quote/588860.CN.md)
- [562600.CN](https://longbridge.com/en/quote/562600.CN.md)

## Related News & Research

- [China’s Clinical Trial Registrations Surpass 5,000 for First Time in 2025](https://longbridge.com/en/news/290539713.md)
- [Broncus shareholders back all AGM resolutions, update articles of association](https://longbridge.com/en/news/286439966.md)
- [China closing in but US still leads in biotech innovation, survey finds](https://longbridge.com/en/news/290431706.md)
- [Lifecare Reschedules Q1 2026 Results Release and Sets Webcast for 15 May](https://longbridge.com/en/news/285590729.md)
- [Ventripoint's VMS+ (TM) 4.0 Submitted for Regulatory Approval in China by Lishman Global Inc.](https://longbridge.com/en/news/284379502.md)